z-logo
open-access-imgOpen Access
Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C
Author(s) -
Tatsuki Ichikawa,
Mio Yamashima,
Shinobu Yamamichi,
Makiko Koike,
Yusuke Nakano,
Tetsurou Honda,
Hiroyuki Yajima,
Osamu Miyazaki,
Yasutaka Kuribayashi,
Tomonari Ikeda,
Takuma Okamura,
Kazuhiko Nakao
Publication year - 2022
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2022.1567
Subject(s) - medicine , bone remodeling , osteoporosis , osteocalcin , femoral neck , bone mineral , endocrinology , hepatitis c virus , bone density , alkaline phosphatase , immunology , biology , virus , biochemistry , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom